Roche Diagnostics' Goddards Green National Distribution Centre Officially Opens

Mid Sussex MP and Minister for Employment Mims Davies officially opened Roche Diagnostics' National Distribution Centre last month.

The new facility in Goddards Green consolidates the pharmaceutical company's commitment to Mid Sussex, with its UK and Ireland headquarters based in Burgess Hill.

Investment in the National Distribution Centre has enabled Roche to increase its operational capacity and has also created skilled jobs in the district, with more than 60 people employed at the purpose-built facility.

Roche Diagnostics' tests and medical devices are distributed to pathology laboratories, GP surgeries and patients across the UK, and the distribution centre ships about 2,000 different types of products a day.

Mrs Davies, unveiled a plaque on the day and said: "I was delighted to formally open Roche Diagnostics' National Distribution Centre here in Mid Sussex and to see how this impressive facility is providing patients with access to critical diagnostics products, as well as also importantly creating more skilled job opportunities for the area."

Geoff Twist, Managing Director, Roche Diagnostics UK & Ireland, said: "The National Distribution Centre at Goddards Green represents our continued commitment to the UK diagnostics industry and supporting the NHS to ensure patients have access to our life-changing diagnostic tests and products now and in the future. This new facility features the latest in distribution technology and will be key to growing our operations in the UK. We are also proud to be creating skilled jobs in the local community."

Allison Brett, Distribution Centre Manager, Roche Diagnostics UK and Ireland said: "It was wonderful to have the Minister formally open our new purpose-built National Distribution Centre and meet some of our exceptional team members. I am extremely proud of the role our centre has played in supporting the NHS throughout the pandemic and we will continue to work tirelessly to support the NHS and patients during this challenging period and beyond."